Anthony Maddaluna
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Anthony Maddaluna
Earlier roles on record: Board Member at Indaptus Therapeutics, Inc. (INDP) until March 18, 2026. Indaptus Therapeutics, Inc. reported in an 8-K filed March 24, 2026 that Anthony Maddaluna resigned as Director, effective March 18, 2026. Indaptus Therapeutics, Inc. reported in an 8-K filed January 2, 2026 that Anthony Maddaluna resigned as member of the Board of Directors.
“Jeffrey A. Meckler, Roger J. Pomerantz, Anthony J. Maddaluna, and William B. Hayes (together, the "Resigning Directors") resigned on March 18, 2026.”
“On December 29, 2025, Michael Newman, Mark Gilbert, and Anthony Maddaluna, members of the Board of Directors (the "Board") of Indaptus Therapeutics, Inc. (the "Company"), each notified the Company of its resignation from the Board effective upon the approval of David Lazar's nominees at the Company's next stockholders' meeting.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
2021-01-01–2026-03-18
Company network
Recorded roles and call appearances connecting this person to public companies.
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.